KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EBIT (2016 - 2025)

Historic EBIT for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $493.0 million.

  • Elevance Health's EBIT fell 645.16% to $493.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year increase of 697.22%. This contributed to the annual value of $2.2 billion for FY2025, which is 697.22% up from last year.
  • As of Q4 2025, Elevance Health's EBIT stood at $493.0 million, which was down 645.16% from $625.0 million recorded in Q3 2025.
  • In the past 5 years, Elevance Health's EBIT ranged from a high of $625.0 million in Q3 2025 and a low of $291.0 million during Q1 2021
  • Over the past 5 years, Elevance Health's median EBIT value was $440.5 million (recorded in 2023), while the average stood at $446.6 million.
  • Per our database at Business Quant, Elevance Health's EBIT surged by 60175.44% in 2021 and then crashed by 645.16% in 2025.
  • Over the past 5 years, Elevance Health's EBIT (Quarter) stood at $352.0 million in 2021, then increased by 5.97% to $373.0 million in 2022, then soared by 41.82% to $529.0 million in 2023, then fell by 0.38% to $527.0 million in 2024, then fell by 6.45% to $493.0 million in 2025.
  • Its EBIT stands at $493.0 million for Q4 2025, versus $625.0 million for Q3 2025 and $486.0 million for Q2 2025.